University of Oxford

GSK and Oxford University Collaborate on Cancer Vaccines

GSK and the University of Oxford have entered a new research collaboration focused on the potential of cancer prevention through vaccination. The program, in which GSK plans to invest up to £50 million over a minimum of three years, will conduct translational research, exploring precancer biology to generate key insights on how cancer develops in humans that could inform future development of cancer vaccines.

Digging in the Digital Mountain

Astellas, GSK Vie to Make 'High Altitude' Anaemia Pill

ExpreS2ion Biotechnologies and Oxford's Jenner Institute Enter Licensing Agreement